Antiplatelet agents make a comeback in ST-elevation myocardial infarction

Am Heart J. 2007 Oct;154(4):603-6. doi: 10.1016/j.ahj.2005.04.036.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / therapeutic use
  • Antifibrinolytic Agents / therapeutic use
  • Clopidogrel
  • Drug Therapy, Combination
  • Humans
  • Myocardial Infarction / drug therapy*
  • Piperazines / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride
  • Purinergic P2 Receptor Antagonists
  • Thiophenes / therapeutic use
  • Ticagrelor
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Piperazines
  • Platelet Aggregation Inhibitors
  • Purinergic P2 Receptor Antagonists
  • Thiophenes
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticagrelor
  • Adenosine
  • Ticlopidine